NIAID: ‘Outdated information’ may have skewed efficacy data from AstraZeneca Covid vaccine trial
The results of a recent US trial for AstraZeneca’s Covid-19 vaccine may have used data that is no longer relevant, raising questions about accuracy, the US National Institute of Allergy and Infectious Diseases (NIAID) has said.